bf/NYSE:EW_icon.jpeg

NYSE:EW

Edwards Lifesciences Corporation

  • Stock

USD

Last Close

85.06

03/05 19:59

Market Cap

44.42B

Beta: 1.01

Volume Today

1.56M

Avg: 3.25M

PE Ratio

36.59

PFCF: 66.37

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
294.95M
-
302.85M
2.68%
318.35M
5.12%
368.25M
15.67%
475.75M
29.19%
580.95M
22.11%
623.95M
7.40%
721.60M
15.65%
764.50M
5.95%
801.10M
4.79%
average payables
61.55M
-
53.30M
13.40%
61.05M
14.54%
80.50M
31.86%
106.85M
32.73%
125.30M
17.27%
157.20M
25.46%
188.45M
19.88%
200.50M
6.39%
203.20M
1.35%
average receivables
337.75M
-
326.50M
3.33%
334.55M
2.47%
379.35M
13.39%
438.40M
15.57%
499.75M
13.99%
568.20M
13.70%
600.95M
5.76%
633.85M
5.47%
682M
7.60%
book value per share
2.33
-
3.43
47.41%
3.87
12.90%
4.10
5.86%
4.73
15.48%
5.00
5.72%
6.64
32.69%
7.35
10.66%
9.36
27.44%
9.38
0.19%
capex per share
-0.16
-
-0.15
10.74%
-0.16
12.34%
-0.34
106.53%
-0.28
18.47%
-0.39
38.84%
-0.45
15.70%
-0.65
46.82%
-0.53
19.12%
-0.43
19.15%
capex to depreciation
-1.60
-
-1.37
14.77%
-1.62
18.50%
-3.05
88.65%
-2.14
29.82%
-3.12
45.73%
-3.12
0.17%
-3.80
21.87%
-2.45
35.61%
-1.90
22.47%
capex to operating cash flow
-0.23
-
-0.09
60.65%
-0.19
111.38%
-0.31
59.30%
-0.18
43.18%
-0.26
48.70%
-0.24
9.49%
-0.39
63.66%
-0.19
50.71%
-0.22
14.16%
capex to revenue
-0.05
-
-0.04
25.06%
-0.04
5.88%
-0.07
71.76%
-0.05
30.36%
-0.06
27.09%
-0.06
1.38%
-0.09
45.02%
-0.06
32.12%
-0.05
21.95%
cash per share
1.40
-
2.25
61.07%
1.89
15.87%
1.99
5.01%
2.11
6.27%
1.52
27.90%
2.43
59.30%
2.25
7.21%
2.35
4.46%
1.96
16.57%
days of inventory on hand
215.83
-
173.16
19.77%
201.01
16.08%
181.54
9.69%
231.39
27.46%
235.85
1.92%
209.91
11.00%
271.00
29.10%
212.38
21.63%
295.78
39.27%
days payables outstanding
33.82
-
33.96
0.41%
37.79
11.29%
44.45
17.62%
48.62
9.40%
52.07
7.08%
59.09
13.49%
66.37
12.33%
59.77
9.95%
68.21
14.13%
days sales outstanding
58.53
-
51.07
12.75%
50.37
1.37%
51.06
1.38%
49.11
3.82%
52.68
7.27%
50.29
4.53%
50.16
0.26%
46.38
7.54%
47.41
2.22%
debt to assets
0.22
-
0.17
22.04%
0.15
12.92%
0.18
23.37%
0.18
0.21%
0.11
38.69%
0.10
6.20%
0.10
8.22%
0.08
15.45%
0.08
2.68%
debt to equity
0.38
-
0.27
28.25%
0.24
12.19%
0.31
31.01%
0.35
10.22%
0.19
45.36%
0.16
13.46%
0.15
7.16%
0.12
22.14%
0.12
0.65%
dividend yield
0.18
-
0.02
90.61%
0.00
88.94%
0.01
588.49%
0.02
-
0.00
98.19%
earnings yield
0.05
-
0.06
12.12%
0.03
51.37%
0.03
1.87%
0.03
8.28%
0.02
13.88%
0.02
4.40%
0.01
32.72%
0.02
28.41%
0.03
77.03%
0.03
8.01%
enterprise value
7.52B
-
13.51B
79.70%
16.90B
25.10%
19.85B
17.45%
23.99B
20.85%
31.92B
33.08%
48.09B
50.63%
56.31B
17.11%
80.58B
43.09%
46.11B
42.78%
enterprise value over ebitda
19.42
-
-76.37
493.34%
26.01
134.06%
22.42
13.82%
24.00
7.06%
22.96
4.33%
36.14
57.37%
32.44
10.22%
54.32
67.43%
25.20
53.62%
ev to operating cash flow
15.90
-
13.22
16.91%
30.75
132.66%
28.18
8.35%
23.97
14.93%
34.44
43.69%
40.77
18.37%
53.41
31.00%
46.52
12.90%
37.85
18.64%
ev to sales
3.68
-
5.82
58.24%
6.78
16.53%
6.70
1.18%
6.98
4.26%
8.57
22.80%
11.06
28.97%
12.84
16.08%
15.40
19.95%
8.57
44.37%
free cash flow per share
0.54
-
1.45
168.60%
0.69
52.83%
0.76
11.17%
1.30
71.13%
1.09
16.30%
1.44
32.10%
1.04
27.94%
2.25
116.50%
1.54
31.54%
0.01
99.44%
free cash flow yield
0.05
-
0.07
38.66%
0.03
61.96%
0.02
6.29%
0.03
42.27%
0.02
38.41%
0.02
13.27%
0.01
38.57%
0.02
52.46%
0.02
18.87%
0.00
99.46%
graham net net
0.26
-
0.78
203.97%
0.15
80.84%
-0.17
215.98%
-1.17
575.62%
-0.83
29.13%
-0.09
89.74%
-0.65
668.73%
-0.54
17.07%
-0.50
8.08%
graham number
5.53
-
9.90
78.93%
8.17
17.49%
9.07
11.02%
10.23
12.87%
11.38
11.23%
15.82
39.00%
14.79
6.54%
22.54
52.44%
22.78
1.07%
income quality
1.21
-
1.26
4.44%
1.11
11.87%
1.24
11.36%
1.71
38.63%
1.28
25.16%
1.13
12.21%
1.28
13.66%
1.15
10.00%
0.80
30.54%
intangibles to total assets
0.16
-
0.11
30.23%
0.21
81.23%
0.18
10.30%
0.28
51.93%
0.27
2.33%
0.23
15.20%
0.21
10.33%
0.18
15.62%
0.17
0.35%
0
100%
interest coverage
87.40
-
44.69
48.88%
69.11
54.65%
93.31
35.02%
352.66
277.94%
-356.29
201.03%
55.40
115.55%
103.06
86.03%
73.29
28.89%
91.07
24.26%
interest debt per share
0.89
-
0.95
6.74%
0.94
1.11%
1.30
37.96%
1.64
26.36%
0.94
42.60%
1.12
18.75%
1.14
1.96%
1.14
0.39%
1.15
0.95%
inventory turnover
1.69
-
2.11
24.64%
1.82
13.85%
2.01
10.73%
1.58
21.55%
1.55
1.89%
1.74
12.35%
1.35
22.54%
1.72
27.60%
1.23
28.19%
invested capital
0.38
-
0.27
28.25%
0.24
12.19%
0.31
31.01%
0.35
10.22%
0.19
45.36%
0.16
13.46%
0.15
7.16%
0.12
22.14%
0.12
0.65%
market cap
7.35B
-
13.57B
84.69%
17.02B
25.46%
19.96B
17.26%
23.77B
19.10%
32.04B
34.80%
48.59B
51.63%
56.80B
16.90%
80.75B
42.16%
46.18B
42.81%
46.26B
0.17%
net current asset value
560.30M
-
961.70M
71.64%
491.70M
48.87%
349M
29.02%
-169.70M
148.62%
103.60M
161.05%
644.20M
521.81%
428.20M
33.53%
514M
20.04%
610M
18.68%
net debt to ebitda
0.45
-
0.31
29.41%
-0.18
157.93%
-0.12
33.25%
0.22
279.24%
-0.09
139.66%
-0.38
334.47%
-0.28
25.17%
-0.12
58.66%
-0.04
63.49%
net income per share
0.58
-
1.27
117.18%
0.77
39.69%
0.89
16.42%
0.98
10.32%
1.15
17.03%
1.68
45.61%
1.32
21.07%
2.41
82.34%
2.46
1.95%
2.31
5.98%
operating cash flow per share
0.71
-
1.60
126.83%
0.85
46.85%
1.10
29.65%
1.58
43.48%
1.48
6.63%
1.89
27.83%
1.69
10.29%
2.78
64.10%
1.97
29.18%
0.01
99.56%
payables turnover
10.79
-
10.75
0.41%
9.66
10.14%
8.21
14.98%
7.51
8.59%
7.01
6.61%
6.18
11.88%
5.50
10.98%
6.11
11.05%
5.35
12.38%
receivables turnover
6.24
-
7.15
14.61%
7.25
1.39%
7.15
1.36%
7.43
3.98%
6.93
6.78%
7.26
4.75%
7.28
0.26%
7.87
8.15%
7.70
2.17%
research and ddevelopement to revenue
0.16
-
0.15
5.54%
0.15
2.99%
0.15
2.64%
0.16
7.54%
0.17
3.90%
0.17
3.58%
0.17
0.18%
0.17
0.48%
0.18
1.75%
0.18
1.64%
return on tangible assets
0.17
-
0.26
51.22%
0.15
40.89%
0.15
0.89%
0.15
2.03%
0.19
23.10%
0.21
12.51%
0.14
31.62%
0.21
49.26%
0.22
3.74%
revenue per share
3.05
-
3.64
19.11%
3.86
6.11%
4.64
20.24%
5.43
17.07%
5.93
9.25%
6.96
17.32%
7.05
1.24%
8.39
19.16%
8.70
3.58%
9.90
13.83%
roe
0.25
-
0.37
47.33%
0.20
46.58%
0.22
9.98%
0.21
4.47%
0.23
10.70%
0.25
9.74%
0.18
28.67%
0.26
43.08%
0.26
1.76%
roic
0.16
-
0.12
23.58%
0.16
34.27%
0.18
6.73%
0.15
13.24%
0.19
24.62%
0.21
10.26%
0.27
30.00%
0.18
33.97%
0.23
26.96%
sales general and administrative to revenue
0.36
-
0.37
1.33%
0.34
7.64%
0.31
10.52%
0.29
6.10%
0.29
2.00%
shareholders equity per share
2.33
-
3.43
47.41%
3.87
12.90%
4.10
5.86%
4.73
15.48%
5.00
5.72%
6.64
32.69%
7.35
10.66%
9.36
27.44%
9.38
0.19%
stock based compensation to revenue
0.02
-
0.02
10.27%
0.02
3.76%
0.02
4.06%
0.02
6.60%
0.02
6.36%
0.02
1.96%
0.02
12.90%
0.02
1.05%
0.02
12.78%
tangible asset value
1.12B
-
1.79B
60.49%
1.67B
6.84%
1.79B
7.11%
1.40B
21.69%
1.69B
20.34%
2.64B
56.92%
3.07B
16.10%
4.34B
41.53%
4.36B
0.29%
tangible book value per share
1.67
-
2.80
68.32%
2.58
7.92%
2.80
8.37%
2.21
20.91%
2.68
21.32%
4.23
57.62%
4.93
16.51%
6.97
41.37%
7.04
0.99%
working capital
1.38B
-
1.86B
34.78%
1.57B
15.51%
1.71B
8.64%
1.13B
33.66%
1.41B
24.51%
2.08B
47.60%
2.20B
5.55%
2.15B
2.22%
2.07B
3.49%

All numbers in USD (except ratios and percentages)